Intrinsic Value of S&P & Nasdaq Contact Us

Janux Therapeutics, Inc. JANX NASDAQ

NASDAQ Global Market • Healthcare • Biotechnology • US • USD

SharesGrow Score
54/100
3/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$39.80
+164.6%

There have been 50 recent insider transactions recorded for Janux Therapeutics, Inc. (JANX), including 27 buys and 20 sells. Total insider buying was valued at $103.08M and total insider selling at $8.96M.

Notable insiders with recent activity include Go William, Campbell David Alan, Meyer Andrew Hollman. Insider transactions can provide insights into how company leadership views the stock's valuation and future prospects.

Insider Transactions — JANX

Date Name Role Transaction Shares Avg. Price Value Shares Owned
2026-02-02 Go William Chief Medical Officer RSU Award 44,000 - - 44,000
2026-01-26 Go William Officer Unknown - - - -
2026-01-02 Campbell David Alan President and CEO Informative Sell 8,072 $13.73 $110.83K 284,982
2026-01-02 Meyer Andrew Hollman Chief Business Officer Informative Sell 1,879 $13.73 $25.8K 83,095
2026-01-02 Winter Charles M. Chief Technical Officer Informative Sell 2,401 $13.73 $32.97K 77,721
2026-01-02 Diraimondo Thomas Chief Scientific Officer RSU Award 109,900 $13.65 $1.5M 109,900
2026-01-02 Dobek Maria Vice President, Accounting Informative Sell 1,462 $13.73 $20.07K 15,373
2026-01-02 Mciver Zachariah Chief Medical Officer Informative Sell 2,714 $13.73 $37.26K 23,286
2026-01-02 Doyle Janeen Noel Chief Corp. & Bus. Dev. Ofcr RSU Award 36,000 - - 80,000
2025-12-01 Meyer Andrew Hollman Chief Business Officer Informative Sell 633 $33.52 $21.22K 84,974
2025-11-14 Meyer Andrew Hollman Chief Business Officer Informative Sell 3,333 $30.00 $99.99K 84,974
2025-10-28 Meyer Andrew Hollman Chief Business Officer Option Exercise (Sell) 9,999 $4.21 $42.1K 77,333
2025-06-11 Dobmeier Eric Director RSU Award 3,750 - - 9,981
2025-06-11 Capps Vickie L Director RSU Award 11,667 $25.46 $297.04K 11,667
2025-06-11 Barrett Ronald W Director RSU Award 3,750 - - 6,250
2025-06-11 Ra Capital Management, L.p. 10 Percent Owner RSU Award 3,750 - - 6,250
2025-06-11 Gujrathi Sheila Director RSU Award 11,667 $25.46 $297.04K 11,667
2025-06-11 Mcnulty Alana B. Director RSU Award 3,750 - - 6,250
2025-06-11 Kung Winston Director RSU Award 3,750 - - 6,250
2025-06-11 Hernday Natasha Director RSU Award 3,750 - - 8,731
2025-06-11 Simson Jake Director RSU Award 3,750 - - 6,250
2025-06-02 Doyle Janeen Noel Chief Corp. & Bus. Dev. Ofcr RSU Award 44,000 - - 44,000
2025-05-14 Doyle Janeen Noel Officer Unknown - - - -
2025-05-01 Meyer Andrew Hollman Chief Business Officer Informative Sell 400 $32.60 $13.04K 82,139
2025-04-21 Meyer Andrew Hollman Chief Business Officer Informative Sell 3,334 $30.00 $100.02K 82,139
2025-03-07 Ra Capital Management, L.p. 10 Percent Owner Informative Buy 110,206 $31.02 $3.42M 10,141,287
2025-03-06 Ra Capital Management, L.p. 10 Percent Owner Informative Buy 372,093 $30.78 $11.45M 10,031,081
2025-03-05 Ra Capital Management, L.p. 10 Percent Owner Informative Buy 304,287 $30.56 $9.3M 9,621,533
2025-03-03 Meyer Andrew Hollman Chief Business Officer Informative Sell 901 $32.85 $29.6K 82,139
2025-02-03 Meyer Andrew Hollman Chief Business Officer Informative Sell 100 $43.60 $4.36K 82,139
2025-01-07 Campbell David Alan President and CEO Informative Sell 5,000 $60.00 $300K 293,054
2025-01-02 Campbell David Alan President and CEO RSU Award 283,500 $53.24 $15.09M 283,500
2025-01-02 Meyer Andrew Hollman Chief Business Officer RSU Award 63,000 $53.24 $3.35M 63,000
2025-01-02 Robinson Byron Chief Strategy Officer RSU Award 28,000 - - 28,000
2025-01-02 Winter Charles M. Chief Technical Officer RSU Award 23,000 - - 77,288
2025-01-02 Diraimondo Thomas Chief Scientific Officer RSU Award 84,000 $53.24 $4.47M 84,000
2025-01-02 Dobek Maria Vice President, Accounting RSU Award 14,000 - - 14,001
2025-01-02 Mciver Zachariah Chief Medical Officer RSU Award 26,000 - - 26,000
2025-01-01 Mciver Zachariah Chief Medical Officer Unknown 83,700 $11.02 $922.37K -
2024-12-24 Campbell David Alan President and CEO Informative Sell 25,000 $56.19 $1.4M 217,054
2024-12-19 Meyer Andrew Hollman Chief Business Officer Option Exercise 9,880 $20.24 $199.97K 77,472
2024-12-03 Campbell David Alan President and CEO Informative Sell 15,000 $67.00 $1.01M 242,054
2024-11-25 Campbell David Alan President and CEO Informative Sell 6,719 $52.04 $349.65K 257,054
2024-11-05 Capps Vickie L Director Other (Buy) 2,305 - - 70,348
2024-11-05 Gujrathi Sheila Director Other (Buy) 4,611 - - 115,139
2024-10-28 Campbell David Alan President and CEO Informative Sell 11,103 $53.94 $598.91K 282,054
2024-10-18 Avalon Ventures Xi, L.p. 10 Percent Owner Informative Sell 104,957 $44.75 $4.7M 401,321
2024-10-18 Ra Capital Management, L.p. 10 Percent Owner Informative Buy 1,200,000 $44.75 $53.7M 9,317,246
2024-10-17 Avalon Ventures Xi, L.p. 10 Percent Owner Option Exercise (Sell) 237 $39.80 $9.43K 6,072
2024-10-16 Avalon Ventures Xi, L.p. 10 Percent Owner Option Exercise (Sell) 1,407 $39.80 $56K 6,309
Informative Buy/Sell — open market transaction (most significant) Uninformative Buy — award, option exercise, conversion Uninformative Sell — tax withholding, award vest sale Neutral — gift, trust, expiry
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message